Exorna Bioscience
Clinical trials sponsored by Exorna Bioscience, explained in plain language.
-
New Huntington's drug enters early human testing
Disease control OngoingThis early-phase study tests an experimental drug called ER2001 in 27 adults with early-stage Huntington's disease. The main goal is to check safety and how the drug moves through the body. Participants receive either the drug or a placebo as an IV once a week for 6 weeks, with f…
Phase: PHASE1, PHASE2 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated May 17, 2026 05:25 UTC
-
New Huntington's drug shows promise in early safety trial
Disease control OngoingThis early study tests a new medicine, ER2001, given by IV for Huntington's disease. It includes 9 adults who already completed a previous ER2001 study. The main goal is to check safety and how the drug moves in the body, while also looking for any signs it might help control the…
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated May 11, 2026 20:38 UTC